| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2023 | 13.26% | Oppenheimer | → $135 | Initiates Coverage On | → Outperform |
| 11/03/2023 | 19.98% | Piper Sandler | $138 → $143 | Maintains | Overweight |
| 10/13/2023 | 25.85% | JMP Securities | $160 → $150 | Maintains | Market Outperform |
| 10/06/2023 | 15.78% | Piper Sandler | $149 → $138 | Maintains | Overweight |
| 08/31/2023 | 5.71% | BMO Capital | $125 → $126 | Upgrades | Market Perform → Outperform |
| 08/15/2023 | 0.68% | Keefe, Bruyette & Woods | $124 → $120 | Maintains | Market Perform |
| 07/12/2023 | 34.24% | JMP Securities | $170 → $160 | Maintains | Market Outperform |
| 07/06/2023 | 28.37% | Piper Sandler | $155 → $153 | Upgrades | Neutral → Overweight |
| 05/18/2023 | 9.07% | B of A Securities | → $130 | Downgrades | Buy → Neutral |
| 04/18/2023 | 18.3% | Keefe, Bruyette & Woods | $148 → $141 | Maintains | Market Perform |
| 04/18/2023 | 42.63% | JMP Securities | → $170 | Reiterates | → Market Outperform |
| 04/04/2023 | 33.4% | Piper Sandler | $153 → $159 | Maintains | Neutral |
| 02/06/2023 | 24.17% | Keefe, Bruyette & Woods | $142 → $148 | Maintains | Market Perform |
| 02/03/2023 | 42.63% | JMP Securities | → $170 | Reiterates | → Market Outperform |
| 01/20/2023 | 18.3% | BMO Capital | → $141 | Initiates Coverage On | → Market Perform |
| 11/22/2022 | 25.85% | Morgan Stanley | $145 → $150 | Maintains | Equal-Weight |
| 11/11/2022 | 37.6% | Janney Montgomery Scott | → $164 | Initiates Coverage On | → Buy |
| 11/07/2022 | 20.82% | Piper Sandler | → $144 | Downgrades | Overweight → Neutral |
| 08/19/2022 | 21.65% | Morgan Stanley | $155 → $145 | Maintains | Equal-Weight |
| 06/29/2022 | 30.04% | Morgan Stanley | → $155 | Initiates Coverage On | → Equal-Weight |
| 08/17/2021 | 20.82% | Wolfe Research | → $144 | Initiates Coverage On | → Peer Perform |
| 05/21/2021 | 39.27% | B of A Securities | → $166 | Initiates Coverage On | → Buy |
| 04/16/2021 | 21.65% | JMP Securities | $140 → $145 | Maintains | Market Outperform |
| 09/03/2020 | -1.84% | Credit Suisse | → $117 | Initiates Coverage On | → Neutral |
| 06/03/2020 | -4.35% | Piper Sandler | $110 → $114 | Maintains | Overweight |
| 04/16/2020 | 17.46% | JMP Securities | $150 → $140 | Maintains | Market Outperform |
| 04/06/2020 | -28.69% | Piper Sandler | $130 → $85 | Maintains | Overweight |
| 03/11/2020 | 9.07% | Piper Sandler | $151 → $130 | Maintains | Overweight |
| 01/22/2020 | 21.65% | Buckingham Research | $142 → $145 | Maintains | Buy |
| 03/01/2019 | — | Compass Point | Initiates Coverage On | → Buy |
What is the target price for Hanover Insurance Gr (THG)?
The latest price target for Hanover Insurance Gr (NYSE: THG) was reported by Oppenheimer on November 16, 2023. The analyst firm set a price target for $135.00 expecting THG to rise to within 12 months (a possible 13.26% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hanover Insurance Gr (THG)?
The latest analyst rating for Hanover Insurance Gr (NYSE: THG) was provided by Oppenheimer, and Hanover Insurance Gr initiated their outperform rating.
When is the next analyst rating going to be posted or updated for Hanover Insurance Gr (THG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hanover Insurance Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hanover Insurance Gr was filed on November 16, 2023 so you should expect the next rating to be made available sometime around November 16, 2024.
Is the Analyst Rating Hanover Insurance Gr (THG) correct?
While ratings are subjective and will change, the latest Hanover Insurance Gr (THG) rating was a initiated with a price target of $0.00 to $135.00. The current price Hanover Insurance Gr (THG) is trading at is $119.19, which is within the analyst's predicted range.